Teamwork Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,188
Closed -$746K 245
2021
Q4
$746K Sell
12,188
-3,973
-25% -$275K 0.14% 146
2021
Q3
$1.21M Sell
16,161
-1,391
-8% -$117K 0.24% 88
2021
Q2
$1.62M Sell
17,552
-2,175
-11% -$185K 0.33% 53
2021
Q1
$1.75M Sell
19,727
-1,510
-7% -$150K 0.41% 43
2020
Q4
$1.98M Buy
21,237
+2,794
+15% +$223K 0.47% 37
2020
Q3
$1.18M Buy
+18,443
New +$1.08M 0.36% 58

Other funds holding ARKG

Teamwork Financial Advisors's ARKG Position: Q1 2022 in Review

Teamwork Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 12,188 shares — an estimated $746K sold.

Teamwork Financial Advisors first reported a position in ARKG in Q3 2020 and held it in 6 quarters. The position peaked at $1.98M in Q4 2020. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Teamwork Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Teamwork Financial Advisors sold 12,188 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $746K.
  • Teamwork Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 6 quarters.
  • Teamwork Financial Advisors's ARK Genomic Revolution ETF position peaked at $1.98M in Q4 2020.
  • 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Teamwork Financial Advisors's 13F filing for Q1 2022, filed 18 Apr 2022.